CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 54 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $61,000 | +24.5% | 58,345 | +28.6% | 0.00% | – |
| Q3 2016 | $49,000 | +444.4% | 45,385 | +272.5% | 0.00% | – |
| Q2 2016 | $9,000 | -99.6% | 12,184 | -99.4% | 0.00% | -100.0% |
| Q1 2016 | $2,299,000 | -54.1% | 1,964,900 | -3.8% | 0.00% | 0.0% |
| Q4 2015 | $5,004,000 | -14.8% | 2,042,501 | +4.3% | 0.00% | -50.0% |
| Q3 2015 | $5,875,000 | -28.0% | 1,958,285 | -0.9% | 0.00% | 0.0% |
| Q2 2015 | $8,165,000 | +920.6% | 1,976,992 | +970.0% | 0.00% | – |
| Q1 2015 | $800,000 | +42.9% | 184,773 | -2.0% | 0.00% | – |
| Q4 2014 | $560,000 | -3.9% | 188,458 | +7.3% | 0.00% | – |
| Q3 2014 | $583,000 | +45.0% | 175,660 | +10.6% | 0.00% | – |
| Q2 2014 | $402,000 | – | 158,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |